Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ia, Multicenter, Double-Blind, Placebo-controlled Study to Evaluate the Safety of CYT-108 for the Therapy of Mild to Moderate Primary Osteoarthritis of the Knee

NCT06263270 is registered in ClinicalTrials.gov with Cytonics Corporation as lead sponsor.

NCT NCT06263270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06263270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ia, Multicenter, Double-Blind, Placebo-controlled Study to Evaluate the Safety of CYT-108 for the Therapy of Mild to Moderate Primary Osteoarthritis of the Knee
Lead sponsor
Cytonics Corporation
Phase
Phase 1
Overall status
Completed
Start date
June 1, 2024
Completion date
October 10, 2025
Enrollment
19 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, osteoarthritis, knee